BIOLASE Inc news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

BIOL 1.13 -0.03 (-2.59%)
price chart
Trending: BIOLASE, Inc. Capital Expenditures Is Exploding Higher
BIOLASE, Inc. (NASDAQ:BIOL) capital expenditures over a trailing-twelve-month period is trending higher which means it is increasing for at least four consecutive quarters.
Alphatec Holdings Inc versus BIOLASE Inc Head to Head Compare
BIOLASE Inc has a higher fundamental rating then Alphatec Holdings Inc which has an impact on the head-to-head comparison. The CML Star Rating is an objective, quantifiable measure of a company's operating and financial condition.
BIOLASE Inc Stock Momentum Hits Weakness
This is a momentum stock rating analysis for BIOLASE Inc (NASDAQ:BIOL) . The company has a two bull momentum rating which indicates some weakness.
Trading Watch: Checking on Unusual Volume on Shares of BIOLASE, Inc. (NASDAQ:BIOL)
Shares of BIOLASE, Inc. (NASDAQ:BIOL) are experiencing unusual volume during today's trading. While the stock price moved along with the volume change, shares are touching $1.23 at the time of writing.
BIOLASE Inc versus Oxford Immunotec Global PLC Head to Head Compare
Oxford Immunotec Global PLC has a higher fundamental rating then BIOLASE Inc which has an impact on the head-to-head comparison.
BIOLASE Inc versus SeaSpine Holdings Corporation Head to Head Compare
BIOLASE Inc has a higher fundamental rating than SeaSpine Holdings Corporation which has an impact on the head-to-head comparison.
Biolase Inc. (BIOL) to Release Earnings on Monday
Biolase logo Biolase Inc. (NASDAQ:BIOL) is set to post its Q216 quarterly earnings results on Monday, August 1st. Analysts expect Biolase to post earnings of ($0.03) per share and revenue of $12.90 million for the quarter.
Shares Moving Down on the Week: BIOLASE, Inc. (NASDAQ:BIOL)
BIOLASE, Inc. (NASDAQ:BIOL) stock has moved in a downward direction over the past week, yielding losses for investors.
BIOLASE, Inc. versus Cogentix Medical, Inc. Head to Head Compare
Cogentix Medical, Inc. has a higher fundamental rating then BIOLASE, Inc. which has an impact on the head-to-head comparison.
Insiders Increasing Positions in: BIOLASE, Inc. (NASDAQ:BIOL)
According to the latest SEC filings, insiders at BIOLASE, Inc. (NASDAQ:BIOL) have increased their position in the stock by 132.52% over the past 6 months.